1211533-83-3

Usage

Uses

Used in Pharmaceutical Industry:
5-BROMO-6-METHOXYPYRIDIN-2-AMINE is utilized as an intermediate in the synthesis of pharmaceuticals for its potential biological and pharmacological activities. It plays a crucial role in the development of new drugs, making it an essential component in the pharmaceutical sector.
Used in Agrochemical Industry:
In the agrochemical industry, 5-BROMO-6-METHOXYPYRIDIN-2-AMINE is employed as an intermediate in the synthesis of agrochemicals. Its properties make it suitable for the development of new agrochemical compounds, contributing to advancements in agricultural practices.
Used as an Enzyme Inhibitor:
5-BROMO-6-METHOXYPYRIDIN-2-AMINE has been studied for its potential as an inhibitor of various enzymes. This application type highlights its use in biological research and drug development, where it can help modulate enzyme activity for therapeutic purposes.
Overall, 5-BROMO-6-METHOXYPYRIDIN-2-AMINE is a versatile chemical compound with significant applications across different industries, particularly in the development of pharmaceuticals and agrochemicals, as well as in biological research.

Upstream product

• 89284-11-7 5,6-dibromopyridin-2-ylamine 
• 124-41-4 sodium methylate 
• 67-56-1 methanol 
• 17920-35-3 2-amino-6-methoxypyridine 

Downstream Products

• 1375707-17-7 (2R)-N-[6-Methoxy-5-(2-methyloxazol-5-yl)-2-pyridyl]-4-methyl-2-phenyl-3,5-dihydro-2H-pyrido[3,2-f][1,4]oxazepin-8-amine 
• 149539-81-1 methyl 6-amino-2-methoxypyridine-3-carboxylate 
• 1255701-88-2 (R)-tert-butyl 8-(6-methoxy-5-(1-methyl-1H-pyrazol-4-yl)pyridin-2-ylamino)-2-phenyl-2,3-dihydropyrido[3,2-f][1,4]oxazepine-4(5H)-carboxylate 
• 1255700-94-7 (R)-N-(6-methoxy-5-(1-methyl-1H-pyrazol-4-yl)pyridin-2-yl)-2-phenyl-2,3,4,5-tetrahydropyrido[3,2-f][1,4]oxazepin-8-amine 
• 1255700-28-7 (R)-N-(6-methoxy-5-(4-methyl-1H-imidazol-1-yl)pyridin-2-yl)-4-methyl-2-phenyl-2,3,4,5-tetrahydropyrido[3,2-f][1,4]oxazepin-8-amine 
• 1255700-88-9 (R)-N-(6-methoxy-5-(1-methyl-1H-pyrazol-4-yl)pyridin-2-yl)-4-methyl-2-phenyl-2,3,4,5-tetrahydropyrido[3,2-f][1,4]oxazepin-8-amine 

Relevant academic research and scientific papers

COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PAIN

The invention relates to compounds, pyridine derivatives, and pharmaceutical 10 compositions containing same for use in the treatment of pain. It also relates to specific compounds, compositions comprising the same and uses thereof, in particular in the treatment of pain.

PYRIMIDINE TBK/IKKε INHIBITOR COMPOUNDS AND USES THEREOF

The present invention relates to compounds of Formula I and pharmaceutically acceptable compositions thereof, useful as TBK/IKKε inhibitors.

FUSED MORPHOLINOPYRIMIDINES AND METHODS OF USE THEREOF

The present disclosure relates to Fused Morpholinopyrimidines, pharmaceutical compositions comprising an effective amount of a Fused Morpholinopyrimidine and methods for using a Fused Morpholinopyrimidine in the treatment of a neurodegenerative disease, comprising administering to a subject in need thereof an effective amount of a Fused Morpholinopyrimidine.

LACTAMS AS INHIBITORS OF ROCK

The present invention provides compounds of Formula (I): or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein all the variables are as defined herein. These compounds are selective ROCK inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating cardiovascular, smooth muscle, oncologic, neuropathologic, autoimmune, fibrotic, and/or inflammatory disorders using the same.

FUSED MORPHOLINOPYRIMIDINES AND METHODS OF USE THEREOF

The present disclosure relates to Fused Morpholinopyrimidines, pharmaceutical compositions comprising an effective amount of a Fused Morpholinopyrimidine and methods for using a Fused Morpholinopyrimidine in the treatment of a neurodegenerative disease, comprising administering to a subject in need thereof an effective amount of a Fused Morpholinopyrimidine.

Compounds and Their Use for Treatment of Amyloid Beta-Related Diseases

The present invention relates to novel compounds of formula (I) and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising said compounds, processes for making said compounds, and their use as medicaments for treatment and/or prevention of Aβ-related diseases.